HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John D Altman Selected Research

MHC binding peptide

1/2012Use of replication restricted recombinant vesicular stomatitis virus vectors for detection of antigen-specific T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John D Altman Research Topics

Disease

18Infections
01/2019 - 01/2002
10Virus Diseases (Viral Diseases)
01/2019 - 01/2002
5Viremia
01/2019 - 01/2008
4Tuberculosis (Tuberculoses)
01/2019 - 04/2013
3Neoplasms (Cancer)
02/2021 - 11/2007
3Human Influenza (Influenza)
01/2012 - 06/2002
3Acquired Immunodeficiency Syndrome (AIDS)
07/2009 - 05/2002
2Vaccinia
01/2012 - 05/2002
2Disease Progression
07/2009 - 01/2008
2HIV Infections (HIV Infection)
06/2009 - 12/2007
2Lymphopenia (Lymphocytopenia)
06/2009 - 08/2008
1Skin Diseases (Skin Disease)
01/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2019
1Pathologic Constriction (Stenosis)
05/2015
1Coronary Stenosis (Coronary Artery Stenosis)
05/2015
1Vesicular Stomatitis
01/2012
1Injection Site Reaction
06/2009
1Persistent Infection
08/2008
1Smallpox (Variola)
05/2008
1Yellow Fever
05/2008
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
04/2008
1Meningoencephalitis
01/2008
1Simian Acquired Immunodeficiency Syndrome
01/2008
1Malaria
08/2005
1Communicable Diseases (Infectious Diseases)
02/2002

Drug/Important Bio-Agent (IBA)

12VaccinesIBA
01/2019 - 01/2002
11AntigensIBA
02/2021 - 04/2002
7EpitopesIBA
01/2018 - 01/2002
5Peptides (Polypeptides)IBA
02/2021 - 01/2002
4LipidsIBA
01/2021 - 04/2013
4Antiviral Agents (Antivirals)IBA
01/2019 - 09/2003
3DNA (Deoxyribonucleic Acid)IBA
01/2012 - 05/2002
2Proteins (Proteins, Gene)FDA Link
02/2021 - 01/2012
2Indicators and Reagents (Reagents)IBA
02/2021 - 12/2009
2Viral RNAIBA
01/2018 - 01/2017
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2019
1AntibodiesIBA
01/2018
1HLA-B Antigens (HLA-B)IBA
11/2015
1Vasodilator Agents (Vasodilators)IBA
05/2015
1Adenosine (Adenocard)FDA LinkGeneric
05/2015
1MHC binding peptideIBA
01/2012
1Recombinant ProteinsIBA
01/2012
1PolyproteinsIBA
01/2012
1Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link
12/2009
1AIDS VaccinesIBA
07/2009
1Interleukin-7 (Interleukin 7)IBA
06/2009
1Biological ProductsIBA
06/2009
1Pharmaceutical PreparationsIBA
08/2008
1Fingolimod Hydrochloride (FTY720)FDA Link
08/2008
1Myelin-Oligodendrocyte GlycoproteinIBA
04/2008
1Interleukin-15 (Interleukin 15)IBA
01/2008
1CytokinesIBA
11/2007
1Immunoglobulin G (IgG)IBA
08/2005
1Complement System Proteins (Complement)IBA
08/2004
1Antiviral Restriction FactorsIBA
03/2004
1SuperantigensIBA
07/2002
1Monoclonal AntibodiesIBA
06/2002
1MVA vaccineIBA
05/2002
1Lymphotoxin-alpha (Lymphotoxin)IBA
04/2002
1LipopeptidesIBA
01/2002
1Histocompatibility Antigens Class IIBA
01/2002

Therapy/Procedure

2Immunotherapy
08/2008 - 02/2002
1Therapeutics
12/2007